Quadrant Capital Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.99M | Buy |
6,313
+70
| +1% | +$35.2K | 0.09% | 178 |
|
|
2025
Q4 | $2.91M | Sell |
6,243
-5
| -0.1% | -$2.32K | 0.09% | 175 |
|
|
2025
Q3 | $2.66M | Sell |
6,248
-13
| -0.2% | -$5.04K | 0.09% | 182 |
|
|
2025
Q2 | $2.4M | Buy |
6,261
+97
| +2% | +$35K | 0.09% | 189 |
|
|
2025
Q1 | $2.13M | Buy |
6,164
+3,820
| +163% | +$1.23M | 0.08% | 168 |
|
|
2024
Q4 | $704K | Buy |
2,344
+1
| +0% | +$349 | 0.05% | 257 |
|
|
2024
Q3 | $952K | Buy |
2,343
+49
| +2% | +$17.9K | 0.07% | 210 |
|
|
2024
Q2 | $737K | Buy |
2,294
+178
| +8% | +$57.8K | 0.05% | 244 |
|
|
2024
Q1 | $706K | Buy |
2,116
+2
| +0.1% | +$611 | 0.06% | 254 |
|
|
2023
Q4 | $572K | Sell |
2,114
-161
| -7% | -$39.8K | 0.05% | 273 |
|
|
2023
Q3 | $560K | Buy |
2,275
+158
| +7% | +$43.2K | 0.06% | 252 |
|
|
2023
Q2 | $642K | Sell |
2,117
-5
| -0.2% | -$1.39K | 0.06% | 208 |
|
|
2023
Q1 | $560K | Buy |
2,122
+56
| +3% | +$14.2K | 0.06% | 239 |
|
|
2022
Q4 | $496K | Buy |
2,066
+123
| +6% | +$27.5K | 0.06% | 237 |
|
|
2022
Q3 | $357K | Buy |
1,943
+275
| +16% | +$54.8K | 0.05% | 277 |
|
|
2022
Q2 | $280K | Buy |
1,668
+63
| +4% | +$13.5K | 0.04% | 338 |
|
|
2022
Q1 | $402K | Buy |
1,605
+98
| +7% | +$24.6K | 0.05% | 266 |
|
|
2021
Q4 | $387K | Buy |
1,507
+22
| +1% | +$5.38K | 0.05% | 272 |
|
|
2021
Q3 | $360K | Buy |
1,485
+75
| +5% | +$18.3K | 0.05% | 253 |
|
|
2021
Q2 | $292K | Sell |
1,410
-126
| -8% | -$25.7K | 0.04% | 287 |
|
|
2021
Q1 | $289K | Buy |
1,536
+141
| +10% | +$24.9K | 0.05% | 262 |
|
|
2020
Q4 | $229K | Buy |
1,395
+165
| +13% | +$24.1K | 0.04% | 274 |
|
|
2020
Q3 | $153K | Buy |
1,230
+129
| +12% | +$16K | 0.03% | 322 |
|
|
2020
Q2 | $107K | Sell |
1,101
-822
| -43% | -$85.5K | 0.02% | 436 |
|
|
2020
Q1 | $173K | Buy |
1,923
+612
| +47% | +$79.2K | 0.03% | 412 |
|
|
2019
Q4 | $178K | Buy |
1,311
+92
| +8% | +$12.4K | 0.02% | 710 |
|
|
2019
Q3 | $134K | Sell |
1,219
-870
| -42% | -$112K | 0.02% | 742 |
|
|
2019
Q2 | $272K | Buy |
2,089
+704
| +51% | +$89K | 0.04% | 443 |
|
|
2019
Q1 | $167K | Buy |
1,385
+538
| +64% | +$72.3K | 0.03% | 563 |
|
|
2018
Q4 | $93K | Buy |
847
+85
| +11% | +$11.4K | 0.02% | 637 |
|
|
2018
Q3 | $97K | Hold |
762
| – | – | 0.03% | 420 |
|
|
2018
Q2 | $69K | Buy |
762
+139
| +22% | +$14.1K | 0.02% | 529 |
|
|
2018
Q1 | $51K | Buy |
623
+21
| +3% | +$2.04K | 0.02% | 624 |
|
|
2017
Q4 | $45K | Buy |
602
+37
| +7% | +$2.97K | 0.02% | 647 |
|
|
2017
Q3 | $39K | Sell |
565
-48
| -8% | -$3.86K | 0.02% | 672 |
|
|
2017
Q2 | $42K | Hold |
613
| – | – | 0.02% | 613 |
|
|
2017
Q1 | $46K | Buy |
613
+140
| +30% | +$11.7K | 0.02% | 594 |
|
|
2016
Q4 | $30K | Sell |
473
-2
| -0.4% | -$150 | 0.02% | 611 |
|
|
2016
Q3 | $30K | Sell |
475
-142
| -23% | -$10.9K | 0.02% | 603 |
|
|
2016
Q2 | $41K | Buy |
617
+161
| +35% | +$12.7K | 0.03% | 459 |
|
|
2016
Q1 | $31K | Buy |
456
+216
| +90% | +$15.1K | 0.02% | 534 |
|
|
2015
Q4 | $12K | Buy |
240
+41
| +21% | +$2.86K | 0.01% | 700 |
|
|
2015
Q3 | $14K | Buy |
199
+16
| +9% | +$1.42K | 0.01% | 643 |
|
|
2015
Q2 | $15K | Buy |
+183
| New | +$14.7K | 0.01% | 645 |
|
Other funds holding HCA
VCM
VPM
Quadrant Capital Group's HCA Position: Q1 2026 in Review
Quadrant Capital Group increased its HCA Healthcare (HCA) stake by 1.1% in Q1 2026, buying an estimated $35.2K and bringing the position to 6,313 shares worth $2.99M. The position accounts for 0.09% of the portfolio, ranked #178.
Quadrant Capital Group first reported a position in HCA in Q2 2015 and has held it in 44 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Quadrant Capital Group held 6,313 shares of HCA Healthcare worth $2.99M as of Q1 2026.
- Quadrant Capital Group bought 70 HCA Healthcare shares in Q1 2026, an estimated $35.2K.
- HCA Healthcare made up 0.09% of Quadrant Capital Group's portfolio in Q1 2026, its #178 holding.
- Quadrant Capital Group first reported a position in HCA Healthcare in Q2 2015 and has held it in 44 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.